Active
Company Information for INIVATA LIMITED
THE GLENN BERGE BUILDING, BABRAHAM, CAMBRIDGE, CB22 3FH,
|
Company Registration Number
09144647
Private Limited Company
Active |
Company Name | |
---|---|
INIVATA LIMITED | |
Legal Registered Office | |
THE GLENN BERGE BUILDING BABRAHAM CAMBRIDGE CB22 3FH Other companies in CB2 | |
Company Number | 09144647 | |
---|---|---|
Company ID Number | 09144647 | |
Date formed | 2014-07-23 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2023 | |
Account next due | 30/09/2025 | |
Latest return | 23/07/2015 | |
Return next due | 20/08/2016 | |
Type of accounts | FULL | |
VAT Number /Sales tax ID | GB197221103 |
Last Datalog update: | 2024-09-08 23:05:57 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Registered address | Last known status | Formation date | ||
---|---|---|---|---|
INIVATA INC | Delaware | Unknown |
Officer | Role | Date Appointed |
---|---|---|
TIMOTHY SHANNON |
||
KEITH STUART BLUNDY |
||
JEANNE ELIZABETH BOLGER |
||
JEFFREY H BUCHALTER |
||
IP2IPO SERVICES LIMITED |
||
NITZAN ROSENFELD |
||
ROBERT GILES TANSLEY |
||
PETER JAMES WRIGHTON-SMITH |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
MICHAEL THOMAS STOCUM |
Director | ||
PATRICK TERRY |
Director | ||
ROBBIE WOODMAN |
Director | ||
AMANDA JANE BETTISON |
Company Secretary |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
SUPERX LIMITED | Director | 2016-01-07 | CURRENT | 2015-11-10 | Liquidation | |
CONCIRRUS LTD | Director | 2018-07-23 | CURRENT | 2011-09-30 | Active | |
ARTIOS PHARMA LIMITED | Director | 2018-06-25 | CURRENT | 2015-12-29 | Active | |
CRYSALIN LIMITED | Director | 2018-06-21 | CURRENT | 2007-04-27 | Liquidation | |
SILICON MICROGRAVITY LIMITED | Director | 2018-06-06 | CURRENT | 2014-09-16 | Active | |
IESO DIGITAL HEALTH LIMITED | Director | 2018-04-26 | CURRENT | 2000-09-01 | Active | |
PERACHEM HOLDINGS PLC | Director | 2018-04-26 | CURRENT | 2005-04-15 | Liquidation | |
NEXEON LIMITED | Director | 2018-04-18 | CURRENT | 2006-02-22 | Active | |
EPSILON-3 BIO LIMITED | Director | 2018-04-16 | CURRENT | 2010-06-18 | Liquidation | |
APCINTEX LIMITED | Director | 2018-04-05 | CURRENT | 2014-06-16 | Active | |
KUUR THERAPEUTICS LIMITED | Director | 2018-03-28 | CURRENT | 2005-11-11 | Liquidation | |
OXFORD BIOTRANS LIMITED | Director | 2018-03-27 | CURRENT | 2013-08-14 | Active - Proposal to Strike off | |
OXULAR LIMITED | Director | 2018-03-27 | CURRENT | 2014-11-27 | Active | |
WAVE OPTICS LIMITED | Director | 2018-03-26 | CURRENT | 2012-09-05 | Active | |
TELECTICA LTD | Director | 2018-03-22 | CURRENT | 2012-12-11 | Active | |
NEAL STREET TECHNOLOGIES LIMITED | Director | 2018-03-21 | CURRENT | 2013-05-03 | Active | |
IMPRESSION TECHNOLOGIES LIMITED | Director | 2018-03-13 | CURRENT | 2012-03-30 | Liquidation | |
COVENTRY INTERNATIONAL PRESSING COMPANY LTD | Director | 2018-03-13 | CURRENT | 2015-02-02 | Active - Proposal to Strike off | |
PULMOCIDE LIMITED | Director | 2018-03-12 | CURRENT | 2007-03-23 | Active | |
CARDIAN LIMITED | Director | 2018-03-12 | CURRENT | 2016-12-21 | Liquidation | |
AUTIFONY THERAPEUTICS LIMITED | Director | 2018-03-12 | CURRENT | 2011-02-25 | Active | |
SAM LABS LTD. | Director | 2018-02-28 | CURRENT | 2014-04-23 | Active | |
MISSION THERAPEUTICS LIMITED | Director | 2018-02-15 | CURRENT | 2011-05-11 | Active | |
STORM THERAPEUTICS LIMITED | Director | 2018-02-14 | CURRENT | 2015-04-21 | Active | |
ECONIC TECHNOLOGIES LTD | Director | 2018-02-14 | CURRENT | 2011-06-24 | Active | |
SPIREA LIMITED | Director | 2017-12-14 | CURRENT | 2015-10-09 | Active | |
MOA TECHNOLOGY LIMITED | Director | 2017-10-25 | CURRENT | 2017-08-02 | Active | |
PANCREGENESIS LIMITED | Director | 2017-10-17 | CURRENT | 2017-10-17 | Active - Proposal to Strike off | |
QUANTUM MOTION TECHNOLOGIES LIMITED | Director | 2017-08-11 | CURRENT | 2017-07-14 | Active | |
CHROMOSOL LIMITED | Director | 2017-06-09 | CURRENT | 2017-06-09 | Liquidation | |
EDGETIC LIMITED | Director | 2017-05-15 | CURRENT | 2017-05-15 | Liquidation | |
ALESI SURGICAL LIMITED | Director | 2017-03-02 | CURRENT | 2007-03-01 | Active | |
ART OF XEN LIMITED | Director | 2017-02-22 | CURRENT | 2001-06-15 | Active | |
ACCELERCOMM LTD | Director | 2016-12-21 | CURRENT | 2016-03-04 | Active | |
MICROBIOTICA LIMITED | Director | 2016-12-15 | CURRENT | 2016-07-08 | Active | |
CELLTRON NETWORKS LIMITED | Director | 2016-10-19 | CURRENT | 2016-10-19 | Active - Proposal to Strike off | |
APERIO PHARMA LIMITED | Director | 2016-10-13 | CURRENT | 2016-10-13 | Active - Proposal to Strike off | |
MIXERGY LIMITED | Director | 2016-08-26 | CURRENT | 2014-07-18 | Active | |
UNIPHY LIMITED | Director | 2016-07-11 | CURRENT | 2016-02-12 | Active | |
DYNAMIC VISION SYSTEMS LIMITED | Director | 2016-07-07 | CURRENT | 2014-10-07 | Active - Proposal to Strike off | |
ULTRALEAP HOLDINGS LIMITED | Director | 2016-06-13 | CURRENT | 2016-03-08 | Active | |
DEFENITION LIMITED | Director | 2016-05-11 | CURRENT | 2016-05-11 | Active | |
CERYX MEDICAL LIMITED | Director | 2016-05-03 | CURRENT | 2016-02-12 | Active | |
PULMONIR LIMITED | Director | 2016-03-15 | CURRENT | 2016-02-02 | Active - Proposal to Strike off | |
ASTERION LIMITED | Director | 2016-03-08 | CURRENT | 2000-12-21 | Active | |
FLUID PHARMA LTD | Director | 2016-03-03 | CURRENT | 2016-03-03 | Active | |
ZEETTA NETWORKS LIMITED | Director | 2015-12-22 | CURRENT | 2015-01-20 | Liquidation | |
NAVENIO LIMITED | Director | 2015-12-04 | CURRENT | 2015-10-28 | Active | |
ADJUVANTIX LIMITED | Director | 2015-10-09 | CURRENT | 1999-10-28 | Dissolved 2016-07-12 | |
RELITECT LIMITED | Director | 2015-02-20 | CURRENT | 2014-11-17 | Active - Proposal to Strike off | |
8POWER LIMITED | Director | 2015-01-20 | CURRENT | 2015-01-20 | Active | |
PHASE FOCUS LIMITED | Director | 2014-12-17 | CURRENT | 2006-06-23 | Active | |
ULTRAMATIS LIMITED | Director | 2014-11-19 | CURRENT | 2014-11-19 | Active - Proposal to Strike off | |
DUKOSI LIMITED | Director | 2014-11-19 | CURRENT | 2003-11-27 | Active | |
MAGNOMATICS LIMITED | Director | 2014-11-07 | CURRENT | 2006-07-17 | Active | |
PERPETUUM LIMITED | Director | 2014-10-01 | CURRENT | 2004-06-04 | Active - Proposal to Strike off | |
EIGHT19 LIMITED | Director | 2014-09-22 | CURRENT | 2010-07-22 | Active | |
UMIP PROJECT 001 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Dissolved 2016-09-06 | |
UMIP PROJECT 003 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Active - Proposal to Strike off | |
BOXARR LIMITED | Director | 2014-07-24 | CURRENT | 2003-08-20 | Active | |
EXTRAJECT TECHNOLOGIES LTD | Director | 2014-07-23 | CURRENT | 2013-01-21 | Active - Proposal to Strike off | |
MEDELLA THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2007-02-08 | Active - Proposal to Strike off | |
PH THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2013-03-06 | Active | |
UMIP PROJECT 002 LIMITED | Director | 2014-07-03 | CURRENT | 2014-07-03 | Dissolved 2017-10-17 | |
CREAVO MEDICAL TECHNOLOGIES LIMITED | Director | 2014-04-01 | CURRENT | 2014-01-31 | Liquidation | |
OXSYBIO LIMITED | Director | 2014-03-03 | CURRENT | 2014-03-03 | Liquidation | |
IONIX ADVANCED TECHNOLOGIES LTD | Director | 2013-12-23 | CURRENT | 2011-08-04 | Active | |
SAW DX LIMITED | Director | 2013-08-12 | CURRENT | 2013-03-11 | Active - Proposal to Strike off | |
SPINETIC ENERGY LIMITED | Director | 2013-05-24 | CURRENT | 2012-05-28 | Liquidation | |
UBIQUIGENT LTD | Director | 2013-04-04 | CURRENT | 2009-07-10 | Active | |
AZURI TECHNOLOGIES LTD | Director | 2012-12-21 | CURRENT | 2012-07-10 | Active | |
PHOTOPHARMICA LIMITED | Director | 2012-12-21 | CURRENT | 2012-12-03 | Dissolved 2018-06-12 | |
OXEHEALTH LIMITED | Director | 2012-09-13 | CURRENT | 2012-07-31 | Active | |
OXFORD DRUG DESIGN LIMITED | Director | 2012-07-10 | CURRENT | 2001-10-17 | Active | |
CRYPTOGRAPHIQ LIMITED | Director | 2012-06-25 | CURRENT | 2012-06-25 | Active - Proposal to Strike off | |
SEREN PHOTONICS LIMITED | Director | 2012-03-06 | CURRENT | 2009-11-04 | Active - Proposal to Strike off | |
PHOTOPHARMICA LEEDS LIMITED | Director | 2011-09-22 | CURRENT | 2001-03-06 | Dissolved 2015-08-18 | |
FIRST LIGHT FUSION LIMITED | Director | 2011-06-30 | CURRENT | 2011-03-08 | Active | |
UNION LIFE SCIENCES LIMITED | Director | 2011-04-14 | CURRENT | 2006-02-16 | Active - Proposal to Strike off | |
ARKIVUM LIMITED | Director | 2011-03-24 | CURRENT | 2011-02-15 | Active | |
ANACAIL LIMITED | Director | 2011-02-23 | CURRENT | 2010-11-03 | Liquidation | |
CH4E LIMITED | Director | 2011-02-18 | CURRENT | 2009-01-07 | Dissolved 2016-10-27 | |
MBS DIRECTOR LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MBS SECRETARIAL LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MODERN BIOSCIENCES NOMINEES LIMITED | Director | 2009-08-04 | CURRENT | 2007-06-14 | Active | |
ISTESSO THERAPEUTICS LIMITED | Director | 2009-06-02 | CURRENT | 2005-04-05 | Active | |
C-CAPTURE LIMITED | Director | 2009-05-21 | CURRENT | 2009-05-21 | Active | |
AMAETHON LIMITED | Director | 2009-04-17 | CURRENT | 2003-07-30 | Liquidation | |
AZELLON LTD | Director | 2009-01-05 | CURRENT | 2007-12-07 | Active - Proposal to Strike off | |
POLAR OLED LTD | Director | 2008-11-26 | CURRENT | 2008-11-26 | Active - Proposal to Strike off | |
ENCOS LIMITED | Director | 2008-11-13 | CURRENT | 2007-04-23 | Dissolved 2017-04-11 | |
IKSUDA THERAPEUTICS LIMITED | Director | 2008-09-04 | CURRENT | 2007-11-21 | Active | |
DISPERSIA LIMITED | Director | 2008-08-01 | CURRENT | 2006-01-31 | Dissolved 2014-05-27 | |
DYECAT LIMITED | Director | 2008-08-01 | CURRENT | 2005-10-03 | Dissolved 2014-05-06 | |
CHAMELIC LIMITED | Director | 2008-08-01 | CURRENT | 2006-02-16 | Dissolved 2015-08-11 | |
STRUCTURE VISION LIMITED | Director | 2008-08-01 | CURRENT | 2003-03-20 | Active | |
SUSTAINABLE RESOURCE SOLUTIONS LIMITED | Director | 2008-07-25 | CURRENT | 2007-04-30 | Dissolved 2015-07-14 | |
RIO AI LIMITED | Director | 2008-04-09 | CURRENT | 1997-10-01 | Active | |
EMDOT LIMITED | Director | 2007-08-02 | CURRENT | 2007-08-02 | Active | |
MDL 2016 LIMITED | Director | 2007-02-22 | CURRENT | 2006-02-10 | Dissolved 2018-03-06 | |
SURREY NANOSYSTEMS LIMITED | Director | 2006-11-28 | CURRENT | 1999-06-02 | Active | |
PHARMINOX LIMITED | Director | 2006-09-15 | CURRENT | 2001-12-28 | Active - Proposal to Strike off | |
CAPSANT NEUROTECHNOLOGIES LIMITED | Director | 2006-06-28 | CURRENT | 2002-06-21 | Liquidation | |
EXVASTAT LTD | Director | 2016-12-22 | CURRENT | 2016-05-27 | Active | |
MICROBIOTICA LIMITED | Director | 2016-12-15 | CURRENT | 2016-07-08 | Active | |
CMR SURGICAL LIMITED | Director | 2016-07-15 | CURRENT | 2014-01-27 | Active | |
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED | Director | 2015-10-30 | CURRENT | 2015-07-15 | Active - Proposal to Strike off | |
OXFORD IMMUNOTEC GLOBAL LIMITED | Director | 2013-08-16 | CURRENT | 2013-08-16 | Active |
Date | Document Type | Document Description |
---|---|---|
CONFIRMATION STATEMENT MADE ON 23/07/24, WITH UPDATES | ||
DIRECTOR APPOINTED WARREN STONE | ||
APPOINTMENT TERMINATED, DIRECTOR VISHAL SIKRI | ||
Change of share class name or designation | ||
Memorandum articles filed | ||
Change of share class name or designation | ||
Resolutions passed:<ul><li>Resolution variation to share rights<li>Resolution to adopt memorandum and artciles</ul> | ||
Particulars of variation of rights attached to shares | ||
FULL ACCOUNTS MADE UP TO 31/12/22 | ||
CONFIRMATION STATEMENT MADE ON 23/07/23, WITH UPDATES | ||
FULL ACCOUNTS MADE UP TO 31/12/21 | ||
DIRECTOR APPOINTED CHRISTOPHER MICHAEL SMITH | ||
DIRECTOR APPOINTED JEFFREY SCOTT SHERMAN | ||
APPOINTMENT TERMINATED, DIRECTOR LYNN TETRAULT | ||
Termination of appointment of Kathryn Mckenzie on 2023-02-28 | ||
APPOINTMENT TERMINATED, DIRECTOR KATHRYN MCKENZIE | ||
CONFIRMATION STATEMENT MADE ON 23/07/22, WITH UPDATES | ||
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/22, WITH UPDATES | |
APPOINTMENT TERMINATED, DIRECTOR MARK MALLON | ||
DIRECTOR APPOINTED LYNN TETRAULT | ||
DIRECTOR APPOINTED VISHAL SIKRI | ||
AP01 | DIRECTOR APPOINTED LYNN TETRAULT | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MARK MALLON | |
PSC02 | Notification of Neogenomics, Inc. as a person with significant control on 2021-06-18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/21, WITH UPDATES | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/20 | |
SH01 | 30/06/21 STATEMENT OF CAPITAL GBP 693.05085 | |
AP01 | DIRECTOR APPOINTED MARK MALLON | |
PSC07 | CESSATION OF TOUCHSTONE INNOVATIONS BUSINESSES LLP AS A PERSON OF SIGNIFICANT CONTROL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JEFFREY H BUCHALTER | |
TM02 | Termination of appointment of Timothy Shannon on 2021-06-18 | |
AP03 | Appointment of Kathryn Mckenzie as company secretary on 2021-06-18 | |
SH01 | 18/06/21 STATEMENT OF CAPITAL GBP 693.05083 | |
SH01 | 15/04/21 STATEMENT OF CAPITAL GBP 663.8979 | |
SH01 | 30/03/21 STATEMENT OF CAPITAL GBP 661.04478 | |
SH01 | 22/03/21 STATEMENT OF CAPITAL GBP 660.86609 | |
SH01 | 08/03/21 STATEMENT OF CAPITAL GBP 655.42609 | |
SH01 | 29/01/21 STATEMENT OF CAPITAL GBP 654.76978 | |
SH01 | 24/12/20 STATEMENT OF CAPITAL GBP 589.4761 | |
SH01 | 08/11/20 STATEMENT OF CAPITAL GBP 534.82089 | |
RES11 | Resolutions passed:
| |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH01 | 03/08/20 STATEMENT OF CAPITAL GBP 534.74277 | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/20, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED DOUGLAS VANOORT | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NITZAN ROSENFELD | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JEANNE ELIZABETH BOLGER | |
SH01 | 22/05/20 STATEMENT OF CAPITAL GBP 492.04338 | |
SH01 | 22/05/20 STATEMENT OF CAPITAL GBP 492.04338 | |
AD01 | REGISTERED OFFICE CHANGED ON 12/05/20 FROM The Portway Granta Park Great Abington Cambridge CB21 6GS England | |
AD01 | REGISTERED OFFICE CHANGED ON 12/05/20 FROM The Portway Granta Park Great Abington Cambridge CB21 6GS England | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/19 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/19 | |
SH01 | 18/02/20 STATEMENT OF CAPITAL GBP 449.34398 | |
SH01 | 18/02/20 STATEMENT OF CAPITAL GBP 449.34398 | |
SH01 | 12/12/19 STATEMENT OF CAPITAL GBP 449.21379 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/18 | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/19, WITH UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MICHAEL LEITH ANSTEY | |
AP01 | DIRECTOR APPOINTED DR ROBERT GILES TANSLEY | |
RES11 | Resolutions passed:
| |
SH01 | 01/04/19 STATEMENT OF CAPITAL GBP 448.83879 | |
SH01 | 12/03/19 STATEMENT OF CAPITAL GBP 447.94375 | |
CH01 | Director's details changed for Mr Michael Anstey on 2019-03-11 | |
AP01 | DIRECTOR APPOINTED CLIVE DYLAN MORRIS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ROBERT GILES TANSLEY | |
AP01 | DIRECTOR APPOINTED MR MICHAEL ANSTEY | |
SH01 | 18/01/19 STATEMENT OF CAPITAL GBP 368.93626 | |
SH01 | 26/10/18 STATEMENT OF CAPITAL GBP 334.69968 | |
SH08 | Change of share class name or designation | |
SH01 | 09/08/18 STATEMENT OF CAPITAL GBP 334.42885 | |
SH06 | Cancellation of shares. Statement of capital on 2018-08-09 GBP 279.12360 | |
SH03 | Purchase of own shares | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES12 | Resolution of varying share rights or name | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KEITH STUART BLUNDY | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/18, WITH UPDATES | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/17 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MICHAEL THOMAS STOCUM | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PATRICK TERRY | |
AP02 | Appointment of Ip2Ipo Services Limited as director on 2018-03-07 | |
LATEST SOC | 07/03/18 STATEMENT OF CAPITAL;GBP 300.02185 | |
SH01 | 12/02/18 STATEMENT OF CAPITAL GBP 300.02185 | |
RES01 | ADOPT ARTICLES 12/02/2018 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ROBBIE WOODMAN | |
LATEST SOC | 04/08/17 STATEMENT OF CAPITAL;GBP 222.02185 | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/17, WITH UPDATES | |
PSC05 | PSC'S CHANGE OF PARTICULARS / IMPERIAL INNOVATIONS BUSINESSES LLP / 06/04/2016 | |
PSC07 | CESSATION OF CAMBRIDGE INNOVATION CAPITAL (JERSEY) LTD AS A PSC | |
SH01 | 30/06/17 STATEMENT OF CAPITAL GBP 222.02185 | |
LATEST SOC | 03/07/17 STATEMENT OF CAPITAL;GBP 166.7166 | |
SH01 | 14/03/17 STATEMENT OF CAPITAL GBP 166.7166 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/16 | |
AD01 | REGISTERED OFFICE CHANGED ON 21/03/2017 FROM LI KA SHING CENTRE ROBINSON WAY CAMBRIDGE CB2 0RE | |
SH01 | 23/01/17 STATEMENT OF CAPITAL GBP 165.61050 | |
AP03 | SECRETARY APPOINTED MR TIMOTHY SHANNON | |
TM02 | APPOINTMENT TERMINATED, SECRETARY AMANDA BETTISON | |
LATEST SOC | 25/07/16 STATEMENT OF CAPITAL;GBP 110.30525 | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/07/16, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED DR PETER WRIGHTON-SMITH | |
AA | FULL ACCOUNTS MADE UP TO 31/12/15 | |
AA01 | PREVEXT FROM 31/07/2015 TO 31/12/2015 | |
SH01 | 25/01/16 STATEMENT OF CAPITAL GBP 110.30525 | |
RES01 | ADOPT ARTICLES 25/01/2016 | |
AP01 | DIRECTOR APPOINTED MR JEFFREY H BUCHALTER | |
SH01 | 16/07/15 STATEMENT OF CAPITAL GBP 55.00000 | |
LATEST SOC | 30/07/15 STATEMENT OF CAPITAL;GBP 55 | |
AR01 | 23/07/15 FULL LIST | |
AD02 | SAIL ADDRESS CREATED | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES01 | ALTER ARTICLES 16/07/2015 | |
AP01 | DIRECTOR APPOINTED MR PATRICK TERRY | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / KEITH STUART BLUNDY / 01/11/2014 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR ROBERT GILES TANSLEY / 01/11/2014 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / JEANNE ELIZABETH BOLGER / 01/11/2014 | |
AP01 | DIRECTOR APPOINTED ROBBIE WOODMAN | |
AP01 | DIRECTOR APPOINTED KEITH STUART BLUNDY | |
RES13 | INVESTMENT AGREEMENT/SUBSCRIBING INVESTORS 17/09/2014 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES01 | ADOPT ARTICLES 17/09/2014 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AP01 | DIRECTOR APPOINTED JEANNE ELIZABETH BOLGER | |
AP01 | DIRECTOR APPOINTED MICHAEL THOMAS STOCUM | |
AP01 | DIRECTOR APPOINTED DR ROBERT GILES TANSLEY | |
LATEST SOC | 30/10/14 STATEMENT OF CAPITAL;GBP 35 | |
SH01 | 17/09/14 STATEMENT OF CAPITAL GBP 35.00000 | |
AD01 | REGISTERED OFFICE CHANGED ON 24/09/2014 FROM 52 PRINCES GATE EXHIBITION ROAD LONDON SW7 2PG | |
AP03 | SECRETARY APPOINTED MS AMANDA JANE BETTISON | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as INIVATA LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
84139100 | Parts of pumps for liquids, n.e.s. | |||
84139100 | Parts of pumps for liquids, n.e.s. |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |